24. Tamaki
K. et al. A cicatricial pemphigoid with linear Ig A Deposit. J Dermatol
1990;17:317-321.
25. Hultsch D. et al. Anti-epeligrin cicatricial pemphigoid. Arch Dermatol
1994;130:1521-1529.
26. Yancey K. et al. Studies of patients with anti-epilligrin cicatricial
pemphigoid J Dermatol 1995;22:829-835.
27. Joost T. et al. Cusative agents and pathogenicity in iatrogenic cutaneous
autoinmmunity. Int J Dermatol 1987;26:75-77.
28. Lawrence S, et al. Significantly increassed occurrence of HLA-DQB1 0301
allele in patients with ocular cicatricial pemphigoid. J Invest Dermatol
1997;108:129-132.
29. Welgand D, et al. Direct inmmunofluorescence in bullous pemphigoid;
effects of extent and localization of lession. J Am Acad Dermatol 1989;20:437-438.
30. Kurzhals G, et al. Localised cicatrical pemphigoid of the Brunsting-Perry
with transition into disseminated cicatricial preembedding. Report of a
case proved by preembedding inmmunogold electron microscopy. Arch Dermatol
1995;131:580-585.
31. Rogers R, et al. Desquamative gingivitis clinical, histopathologic immunopathologic
and therapeutic observations. J Am Acad Dermatol 1982;
7:729.
32. Hernández Aguado I, et al. Penfigoide ampolloso en un lactante
de cinco meses. Med Cut I LA. 1982;10:391-394.
33. Oranje A. et al. Bullous pemphigoid in children. Int J Dermatol 1991;30
(5):339-342.
34. Wakelin S, Allen J, Wojnarowska F. Childhood bullous pemphigoid report
of a case with dermal fluorescence on salt-split skin. Br J Dermatol 1995;133:615-618.
35. Joyce Rico. Autoinmmune blistering diseases in children. Seminars in
Dermatol 1995;14:54-59.
36. Klaus F, Margot P. Innmunodermatology update: The inmmunologically mediated
vesiculo bullous disease. May Clin Proc 1991;66:187-188.
37. Shklar G et al. Oral lesions of mucous membrane pemphigoid Arch Otolaryngol
1971;93:354-364.
38. Marx R. E. et al. Cicatricial pemphigoid (benign mucous membrane pemphigoid
J Oral Surg 1980;38:
834-840.
39. Gammon W et al. Direct inmmunofluorescence studies of sodium chloride
separated skin in the differencial diagnosis of bullous pemphigoid and epidermolysis
bullosa acquisita. J Am Acad Dermatol 1990;22:664.
40. Breslow NE, et al. Statistical methods in cancer research: the analysis
case-control studies. Lyon France IARC Scientific publications 1980.
|
41. Venning V, et
al. The association of bullous pemphigoid and malignant disease: a case
control study. Br J Dermatol 1990:123:439-445.
42. Villarroel A, et al. Penfigoide de Lever como manifestación
de neopolasia interna Rev Arg Dermatol 1981;62:146-152.
43. Del Pozo H, et al. Penfigoide ampolloso púrpura hiperglobulinémica
y síndrome linfoproliferativo de células B. Actas Derm Sif
1989;80:739-744.
44. Su D, et al. Paraneoplastic pemphigus: a case with high titer of circulating
anti-basement membrane zone autoantibodies. J am acad Dermatol 1994;30:841-844.
45. Modiano P, et al. Bullous pemphigoid in association with cutaneous
lesions specific to a myelodysplatic syndrome. Br J Dermatol 1997;136:
402-406.
46. Person, et al. Bullous pemphigoid and psoriasis. Does subclinical
bullous pemphigoid exist? Br J Dermatol 1976;95:535.
47. Ruocco P, et al. Pemphigus and bullous pemphigoid due to drugs. J
Invest Dermatol 1991;30(5):307-312.
48. Wallace DJ, et al. Lupus Erythematosus 3erd ed. Philadelphia PA Lea
& Febiger 1987;775.
49. Sander Bullous pemphigoid and dermatitis herpetiformis: mixed bullous
diseases or coexistence of two separate entities? J Cutan Pathol 1989;16:370-374.
50. Mallet D, et al. Bullous pemphigoid associated with captopril drug.
Intell Clin Pharmacol 1989;23:63.
51. Gutiérrez M, et al. Penfigoide ampolloso de tipo eritema anular
centrífugo. Actas Dermo Sif 1986;77:669-671.
52. Nagano T, et al. Childhood bullous pemphigoid:inmmunohistochemical,
inmmunoelectron microscopic and Western blott analysis. J Am Acad Dermatol
1994;30:884-888.
53. Machado, et al. Serological diagnosis of bullous pemphigoid: comparison
of the sensitivity of indirect inmmunofluorescence on salt split skin
to inmmunoblotting. Br J Dermatol 1992;126:236-241.
54. Yancey R, et al. Inmmunologically mediated skin disease. Harrirson
principles of Internal Medicine. 12th ed. 318 McGraw Hill 1991 USA.
55. Peters M, et al. Clinical corelations of linear IgA deposition at
the cutaneus basement membrane zone. J Am Acad Dermatol 1989;20:761-764.
56. Balding S, et al. Cicatricial pemphigoid autoantibodies react with
multiple sites on the BP180 extracellular domain. Br J Invest Dermatol
1996;106:141-146.
57. Neil K. Bullous Pemphigoid J Am Acad Dermatol 1987;16:907-909.
58. Solarte RA. Penfigoide: frecuencia y correlación clínico-patológica.
Revisión de 16 años Centro Dermatológico Pascua.
1998.
|
59. Díaz
LA, et al. End of the Century Review of Skin Blisters. Arch Dermatol 2000;136:106-112.
60. McGrath J, et al. Homozygous t deletion mutation in the gene encoding
the 180 kDA bullous pemphigoid antigen (BPAG2) in a family with generalised
atrophic benign epidermolysis bullosa. J Invest Dermatol 1996;106:771-774.
61. Siegel J, et al. High-dose methylprednisolone in the treatment of bullous
pemphigoid. Arch Dermatol 1984;120:1157-1165.
62. Fivenson D, et al. Nicotinamide and tetracycline therapy of bullous
pemphigoid Arch Dermatol 1994;
130:753-758.
DERMATITIS HERPETIFORME
1. Fitzpatrick’s,
et al. Dermatology in General Medicine. New York. McGraw Hill. 5th edition.
1999;(1):709-715.
2. Polanco Y, et al. Dermatitis Herpetiforme. Piel 1994;9:487-495.
3. Jeffrey C, et al. The incidence and prevalence of dermatitis herpetiformis
in Utah Arch Dermatol 1992; 128:1608-1610.
4. Pazderka SE, et al. Dermatitis Herpetiformis and linear bullous dermatosis.
Dermatol Clin 1993;11: 511-524.
5. Wojnarowska F, et al. Eds. Management of Blistering Diseases. New York.
Raven Press 1990;139-160.
6. Lever’s WF, et al. Histopathology of the skin. Lippincot-raven.
Philadelphia New York 8th edition. 1997;
7. Habif TP. Clinical Dermatology, 3a Ed. St. Louis Missouri: Mosby, 1996;
504-507.
8. Lätecnoja H, et al. Oral mucosa is frecuently affected in patients
with dermatitis herpetiformis. Arch Dermatol. 1998;134:756-758.
9. Karpati S, et al. Dermatitis Herpetiformis bodies. Ultraestructural
study on the skin of patients using direct preembedding inmmunogold labeling.
Arch. Dermatol 1990;126:
1469-1474.
10. Kawana S, et al. Confocal laser scanning microscopic and inmmunoelectron
microscopic studies of the anatomical distribution of fibrillar IgA deposits
in dermatitis herpetiformis. Arch Dermatol 1993;129:456-459.
11. Zone JJ, et al. The position of granular IgA relative to clinical
lesions in dermatitis herpetiformis. Arch. Dermatol 1996;132:912-918.
12. Kumar V, et al. Serologic markers of gluten sensitive enteropathy
in bullous diseases. Arch Dermatol 1992;
128:1474-1478.
13. Garioch JJ, et al. Failure of intradermal skin testing with gluten
to produce delayed hypersensitivity reactions in patients with dermatitis
herpetiformis. Br J Dermatol 1995;132:698-702.
|